Kymriah-话题@MedSci

#Kymriah#

12篇内容 | 941人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2025304, encodeId=193d20253049c, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=欧盟CHMP为两款CAR-T疗法Carvykti和Kymriah大开绿灯, objectType=article, longId=301794, objectId=e0bb301e9432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0bb301e9432, replyNumber=0, likeNumber=66, createdTime=2022-06-09, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0bb301e9432, moduleTitle=欧盟CHMP为两款CAR-T疗法Carvykti和Kymriah大开绿灯, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0bb301e9432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025302, encodeId=5f9a2025302ba, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=FDA授予Kymriah治疗滤泡性淋巴瘤再生医学高级疗法（RMAT）认定, objectType=article, longId=192833, objectId=390d19283388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=390d19283388, replyNumber=0, likeNumber=70, createdTime=2021-02-03, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=390d19283388, moduleTitle=FDA授予Kymriah治疗滤泡性淋巴瘤再生医学高级疗法（RMAT）认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=390d19283388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025303, encodeId=fd442025303c0, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=诺华CAR-T疗法Kymriah：达到滤泡性淋巴瘤试验终点, objectType=article, longId=198822, objectId=494f19882295, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=494f19882295, replyNumber=0, likeNumber=74, createdTime=2020-11-16, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=494f19882295, moduleTitle=诺华CAR-T疗法Kymriah：达到滤泡性淋巴瘤试验终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=494f19882295)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025297, encodeId=4b5a202529e1e, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=诺华Kymriah治疗DLBCL全新14个月随访数据：完全缓解率40%, objectType=article, longId=141068, objectId=eda7141068fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eda7141068fb, replyNumber=0, likeNumber=74, createdTime=2018-11-19, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eda7141068fb, moduleTitle=诺华Kymriah治疗DLBCL全新14个月随访数据：完全缓解率40%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eda7141068fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025301, encodeId=0f0520253016c, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=日本即将批准诺华CAR-T药物Kymriah上市，可能纳入日本国民健康保险系统, objectType=article, longId=160817, objectId=c87c16081ebb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c87c16081ebb, replyNumber=0, likeNumber=85, createdTime=2020-01-08, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c87c16081ebb, moduleTitle=日本即将批准诺华CAR-T药物Kymriah上市，可能纳入日本国民健康保险系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c87c16081ebb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025299, encodeId=e2d020252992f, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=NICE拒绝将诺华的CAR-T疗法Kymriah（标价37万美元）用于治疗淋巴瘤, objectType=article, longId=149144, objectId=4fbb149144f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fbb149144f6, replyNumber=0, likeNumber=85, createdTime=2019-08-11, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fbb149144f6, moduleTitle=NICE拒绝将诺华的CAR-T疗法Kymriah（标价37万美元）用于治疗淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fbb149144f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025295, encodeId=7b44202529555, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病, objectType=article, longId=128476, objectId=1e4c1284e6be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e4c1284e6be, replyNumber=0, likeNumber=60, createdTime=2018-02-08, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e4c1284e6be, moduleTitle=NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e4c1284e6be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025300, encodeId=27b82025300ff, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=诺华通过收购加速Kymriah中国上市进程国内CAR-T竞争趋热, objectType=article, longId=150500, objectId=4d1c15050082, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d1c15050082, replyNumber=0, likeNumber=82, createdTime=2019-01-12, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d1c15050082, moduleTitle=诺华通过收购加速Kymriah中国上市进程国内CAR-T竞争趋热, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d1c15050082)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025293, encodeId=49452025293f9, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=诺华的Kymriah在血癌中表现出持久应答, objectType=article, longId=123089, objectId=002e12308911, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=002e12308911, replyNumber=0, likeNumber=72, createdTime=2018-07-26, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=002e12308911, moduleTitle=诺华的Kymriah在血癌中表现出持久应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=002e12308911)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025298, encodeId=9c7e202529837, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=诺华CAR-T细胞疗法Kymriah获得加拿大批准上市, objectType=article, longId=148598, objectId=6a66148598f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a66148598f0, replyNumber=0, likeNumber=129, createdTime=2018-11-02, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a66148598f0, moduleTitle=诺华CAR-T细胞疗法Kymriah获得加拿大批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a66148598f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025296, encodeId=f8882025296cf, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=【重磅】厉害了！FDA批准Kymriah用于复发/难治大B细胞淋巴瘤治疗, objectType=article, longId=137081, objectId=3c9113e08130, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c9113e08130, replyNumber=0, likeNumber=81, createdTime=2018-09-01, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c9113e08130, moduleTitle=【重磅】厉害了！FDA批准Kymriah用于复发/难治大B细胞淋巴瘤治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c9113e08130)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025294, encodeId=3d9f2025294ba, content=<a href='/topic/show?id=e8b01060688' target=_blank style='color:#2F92EE;'>#Kymriah#</a>, objectTitle=欧盟，美国在加速审查诺华的CAR-T疗法Kymriah, objectType=article, longId=126809, objectId=17ef12680968, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17ef12680968, replyNumber=0, likeNumber=77, createdTime=2018-10-18, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17ef12680968, moduleTitle=欧盟，美国在加速审查诺华的CAR-T疗法Kymriah, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17ef12680968)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Kymriah

2020-05-29

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

欧盟CHMP为两款CAR-T疗法Carvykti和Kymriah大开绿灯

2022-06-09

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

FDA授予Kymriah治疗滤泡性淋巴瘤再生医学高级疗法（RMAT）认定

2021-02-03

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

诺华CAR-T疗法Kymriah：达到滤泡性淋巴瘤试验终点

2020-11-16

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

诺华Kymriah治疗DLBCL全新14个月随访数据：完全缓解率40%

2018-11-19

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

日本即将批准诺华CAR-T药物Kymriah上市，可能纳入日本国民健康保险系统

2020-01-08

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

NICE拒绝将诺华的CAR-T疗法Kymriah（标价37万美元）用于治疗淋巴瘤

2019-08-11

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病

2018-02-08

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

诺华通过收购加速Kymriah中国上市进程国内CAR-T竞争趋热

2019-01-12

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

诺华的Kymriah在血癌中表现出持久应答

2018-07-26

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

诺华CAR-T细胞疗法Kymriah获得加拿大批准上市

2018-11-02

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

【重磅】厉害了！FDA批准Kymriah用于复发/难治大B细胞淋巴瘤治疗

2018-09-01

grace5700 (审核中...)

前往app查看评论内容

#Kymriah#

欧盟，美国在加速审查诺华的CAR-T疗法Kymriah

2018-10-18

科室
- - 订阅+
  - 更多科室
工具
服务